{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:01:20Z","timestamp":1792450880716,"version":"4.5.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The understanding of how the host immune response differs in T-cell phenotype and memory formation during SARS-CoV-2 infection in liver transplant recipients (LTRs) remains limited. LTRs who recovered from COVID-19 infection without prior vaccination represent a unique population for studying immune responses to SARS-CoV-2. Six LTRs with positive neutralizing antibodies (nAb+) and six LTRs with negative nAb (nAb-) were included at 6 months following COVID-19 infection. It was found that nAb+ LTRs had higher anti-RBD IgG titers and greater neutralizing percent inhibition compared to nAb- LTRs. Fifteen T-cell subsets were identified in COVID-19 convalescent LTRs, and it was shown that only terminal effector CD8+ - 3 decreased in the nAb+ group, while elevated IL-10 expression levels were found in the nAb- group. After stimulation with the SARS-CoV-2 XBB spike peptide pool <jats:italic>in vitro<\/jats:italic>, it was observed that the nAb+ group exhibited an increase in effector memory CD4+ cells with lower PD-1 expression, a reduction in effector memory CD4+ - 2 cells, and terminal effector CD8+ - 3 cells, while the nAb- group showed high expression of CTLA-4 and IL-10 in terminal effector CD8+ - 3 cells. Four SARS-CoV-2-specific T-cell subsets were identified, with high expression of TNF-\u03b1 and IFN-\u03b3 in terminal effector CD8+ - 1 and terminal effector CD8+ - 2 cells in both groups. Perforin was mainly detected in terminal effector CD8+ - 2 cells in nAb+ LTRs. In addition to these proportional differences, stem cell memory CD4+ cells with higher IL-17A expression and stem cell memory CD8+ cells with higher CTLA-4 expression were also found in nAb- LTRs. These findings suggest that LTRs who developed nAb+ following SARS-CoV-2 infection exhibit stronger T-cell responses, with more robust immune activation and memory recall, compared to nAb- LTRs. This study underscores the importance of understanding T-cell responses during SARS-CoV-2 recovery for guiding vaccination strategies and managing immunity in LTRs.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1420150","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T05:33:23Z","timestamp":1743572003000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Distinct immune memory induced by SARS-CoV-2 in convalescent liver transplant recipients"],"prefix":"10.3389","volume":"16","author":[{"given":"Mengcheng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binwei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuangzhuang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gongming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yabo","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"101639","DOI":"10.1016\/j.clinre.2021.101639","article-title":"Covid-19 in liver transplant recipients: the French SOT COVID registry","volume":"45","author":"Dumortier","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.04.020","article-title":"Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients","volume":"75","author":"Rabinowich","year":"2021","journal-title":"J Hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/joim.v290.6","article-title":"Immunogenicity of SARS-CoV-2 mRNA vaccine in solid organ transplant recipients","volume":"290","author":"Holden","year":"2021","journal-title":"J Intern Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2022.06.028","article-title":"Humoral and cellular immune response after third and fourth SARS-coV-2 mRNA vaccination in liver transplant recipients","volume":"20","author":"Harberts","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.02.007","article-title":"Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients","volume":"78","author":"Luxenburger","year":"2023","journal-title":"J Hepatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.954177","article-title":"Immunogenicity profiling and distinct immune response in liver transplant recipients vaccinated with SARS-CoV-2 inactivated vaccines","volume":"13","author":"Duan","year":"2022","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16599","article-title":"Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients","volume":"21","author":"Caballero-Marcos","year":"2021","journal-title":"Am J Transplant"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00625-9","article-title":"T cell-oriented strategies for controlling the COVID-19 pandemic","volume":"21","author":"Noh","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S359919","article-title":"Evaluating the response and safety of inactivated COVID-19 vaccines in liver transplant recipients","volume":"15","author":"Tu","year":"2022","journal-title":"Infect Drug Resist"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.10.042","article-title":"Poor immune response to coronavirus disease vaccines in decompensated cirrhosis patients and liver transplant recipients","volume":"40","author":"Kulkarni","year":"2022","journal-title":"VACCINE"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2023.03.003","article-title":"Long term SARS-CoV-2-specific cellular immunity after COVID-19 in liver transplant recipients","volume":"56","author":"Citores","year":"2023","journal-title":"J Microbiol Immunol Infect"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16708","article-title":"T cell-mediated response to SARS-CoV-2 in liver transplant recipients with prior COVID-19","volume":"21","author":"Fernandez-Ruiz","year":"2021","journal-title":"Am J Transplant"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abc8413","article-title":"The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients","volume":"5","author":"Premkumar","year":"2020","journal-title":"Sci Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.04.023","article-title":"Detection of SARS-coV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals","volume":"52","author":"Ni","year":"2020","journal-title":"IMMUNITY"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000639","article-title":"CD8(+)CD57(+) T cells exhibit distinct features in human non-small cell lung cancer","volume":"8","author":"Huang","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41421-021-00250-9","article-title":"Immune memory in convalescent patients with asymptomatic or mild COVID-19","volume":"7","author":"Long","year":"2021","journal-title":"Cell Discovery"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00487","article-title":"The role of PD-1 in acute and chronic infection","volume":"11","author":"Jubel","year":"2020","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01510-4","article-title":"CD4(+) T cell memory","volume":"24","author":"Kunzli","year":"2023","journal-title":"Nat Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-07-2103","article-title":"Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells","volume":"101","author":"Brenchley","year":"2003","journal-title":"BLOOD"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.9.5771","article-title":"IL-10: the master regulator of immunity to infection","volume":"180","author":"Couper","year":"2008","journal-title":"J Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.782441","article-title":"Clonally expanded virus-specific CD8 T cells acquire diverse transcriptional phenotypes during acute, chronic, and latent infections","volume":"13","author":"Kuhn","year":"2022","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000798","article-title":"Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cells","volume":"6","author":"Makedonas","year":"2010","journal-title":"PloS Pathog"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1420150\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T05:33:24Z","timestamp":1743572004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1420150\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":22,"alternative-id":["10.3389\/fimmu.2025.1420150"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1420150","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"article-number":"1420150"}}